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Abstract
AMPylation, the post-translational modification with adenosine monophosphate (AMP), is
catalyzed by effector proteins from a variety of pathogens. Legionella pneumophila is thus
far the only known pathogen that, in addition to encoding an AMPylase (SidM/DrrA), also
encodes a deAMPylase, called SidD, that reverses SidM-mediated AMPylation of the vesi-
cle transport GTPase Rab1. DeAMPylation is catalyzed by the N-terminal phosphatase-like
domain of SidD. Here, we determined the crystal structure of full length SidD including the
uncharacterized C-terminal domain (CTD). A flexible loop rich in aromatic residues within
the CTD was required to target SidD to model membranes in vitro and to the Golgi appara-
tus within mammalian cells. Deletion of the loop (ǻloop) or substitution of its aromatic phe-
nylalanine residues rendered SidD cytosolic, showing that the hydrophobic loop is the
primary membrane-targeting determinant of SidD. Notably, deletion of the two terminal
alpha helices resulted in a CTD variant incapable of discriminating between membranes of
different composition. Moreover, a L. pneumophila strain producing SidDǻloop phenocopied
a L. pneumophila ǻsidD strain during growth in mouse macrophages and displayed pro-
longed co-localization of AMPylated Rab1 with LCVs, thus revealing that membrane target-
ing of SidD via its CTD is a critical prerequisite for its ability to catalyze Rab1 deAMPylation
during L. pneumophila infection.
Author summary
The frequency of Legionnaires’ disease outbreaks, a serious pneumonia caused by the
intracellular pathogen Legionella pneumophila, has increased more than 4-fold between
the years 2000 and 2015 [CDC, Summary of Notifiable Diseases, United States, 2015]. L.
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pneumophila secretes hundreds of bacterial effectors to manipulate host cell processes.
Rab GTPases, which control intracellular vesicle trafficking in eukaryotes, are a known
target of Legionella effectors. SidM and SidD both target host cell Rab1, but with opposing
activities. While SidM catalyzes the attachment of adenosine monophosphate (AMP) to
Rab1, SidD catalyzes AMP removal from Rab1, a process known as deAMPylation. Here
we present the crystal structure of full length SidD, including the previously uncharacter-
ized C-terminal domain (CTD). We discovered that the CTD assumed a unique fold that
was critical for membrane localization of SidD within host cells, and that this localization
was dependent on two structural elements: a stretch of hydrophobic amino acid residues
that represents a general membrane targeting determinant, and a two-helix bundle that
functions as the specificity determinant. Deletion of either of these elements interfered
with the correct localization of SidD within mammalian cells, confirming that positioning
of bacterial effectors is critically important for their biological function.
Introduction
Altering the function of host proteins through post-translational modification is a popular
strategy among microbial pathogens [1]. While some modifications like ubiquitination or
phosphorylation are almost universal among eukaryotic proteins, others such as phosphocho-
lination and AMPylation are less frequent yet equally fascinating. AMPylation (also known as
adenylylation) was first described in 1967 for the Escherichia coli enzyme GS-ATase (glutamine
synthetase adenylyl transferase; GlnE) which modifies the glutamine synthetase with adeno-
sine monophosphate (AMP) [2, 3]. More than 40 years passed before AMPylation activity was
rediscovered in translocated effectors from Vibrio parahemolyticus (VopS) [4],Histophilus
somnii (IbpA) [5], and L. pneumophila (SidM/DrrA) [6]. In each of these newer cases, the
AMPylated host targets were Rho or Rab family small guanine nucleotide binding proteins
(GTPases) that regulate a wide variety of processes in cells.
The activation state of Rab GTPases is determined by the type of guanine nucleotide they
are bound to [7]. The GDP-bound form is inactive, whereas the GTP-bound conformation is
active. Activation of Rab GTPases is stimulated by GDP/GTP exchange factors (GEFs), while
GTPase-activating proteins (GAPs) stimulate the intrinsic GTP hydrolysis activity of Rabs,
thereby promoting conversion of GTP to GDP and, consequently, Rab inactivation [7]. In
their active form, Rab GTPases are anchored to membranes via geranylgeranyl lipid groups
that are covalently attached to C-terminal cysteine residues, whereas inactive GTPases are
chaperoned to the cytosol by GDP dissociation inhibitor (GDI) [7, 8].
L. pneumophila is a facultative intracellular pathogen that, upon inhalation of contaminated
water droplets, can enter the human lung and cause Legionnaires’ pneumonia, a potentially
fatal disease that primarily impacts individuals with a weakened immune system [9]. Upon
phagocytosis by monocytes such as alveolar macrophages, L. pneumophila translocates close to
300 effector proteins into the host cytosol to bypass cellular defense mechanisms and establish
a safe replication compartment, the Legionella-containing vacuole (LCV) [10, 11]. Effector
translocation requires a functional type IV secretion system (T4SS) called Dot/Icm [12, 13],
and interference with this process by disrupting or mutating dot/icm genes renders L. pneumo-
phila avirulent, underscoring the importance of the effectors for host cell manipulation.
During infection, L. pneumophila acquires material from various membrane trafficking
pathways in order to convert the originally plasma membrane-derived vacuole into a camou-
flaged endoplasmic reticulum (ER)-like compartment [14]. Rab GTPases control vesicle
PLOS PATHOGENS Membrane targeting of SidD
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008734 August 27, 2020 2 / 26
stemcoalition.eu/members/basque-government)
[KK-2017/00067; KK- 2018/00050], Fundación
BBVA (https://www.fbbva.es/en/)
[IN17_BBM_BAS_0054], and the Severo Ochoa
Excellence Program (http://www.ciencia.gob.es/
portal/site/MICINN/excellentinstitutions)[SEV-
2016-0644] to A.H. The funders had no role in
study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
trafficking within eukaryotic cells and are, thus, frequently manipulated by intracellular patho-
gens, including L. pneumophila [15, 16]. Rab1 plays a key role in the transport of early secre-
tory vesicles from the ER to the Golgi [17]. The effector SidM (or DrrA) recruits Rab1 to the
LCV surface early during infection, activates it by catalyzing GDP/GTP exchange, and AMPy-
lates it [6, 18–22]. AMPylated Rab1 is protected from inactivation by both bacterial and host
GAPs and, therefore, remains in an active GTP-bound form [6]. Accumulation of Rab1 on
LCVs peaks around 2 hours post infection [18, 19]. Inactivation and removal of Rab1 is initi-
ated upon translocation of the effector SidD which deAMPylates Rab1, thereby priming it for
inactivation by the L. pneumophila GAP LepB and causing its gradual removal from the LCV
4–6 hours after bacterial uptake [23, 24]. L. pneumophilamutants lacking SidD (ïsidD) fail to
deAMPylate Rab1, resulting in a prolonged co-localization of AMPylated Rab1 with LCVs [23,
24]. The same observation has been made for a L. pneumophila strain lacking the Rab1 GAP
LepB (ïlepB), showing that both SidD and LepB cooperate in the deAMPylation and subse-
quent de-activation of Rab1 during L. pneumophila infection [23, 24].
SidD is a protein of 507 amino acids with no significant sequence homology to other entries
in the database. Using protein crystallography, we recently succeeded in obtaining structural
information about the N-terminal deAMPylase domain of SidD spanning residues 37 to 350
[25]. This domain, which is sufficient to catalyze deAMPylation in vitro, possesses noticeable
similarity to metal-dependent protein phosphatases of the PPM family, most notably human
PP2Cċ and bacterial PstP [25]. The catalytic site of SidD is comprised of a binuclear metal cen-
ter with strong dependence on magnesium ions, which are coordinated in part by three aspar-
tate residues (D92, D110, D326) [25]. Substitution of any of the three aspartate residues with
alanine abolished the deAMPylation activity of SidD [25]. As a consequence, a L. pneumophila
strain producing SidD(D92A) phenocopied a ïsidD strain and displayed prolonged co-locali-
zation with Rab1 during infection [25].
The function of the carboxy-terminal domain of SidD (CTD) has remained unclear. Trun-
cated SidD variants lacking a complete CTD failed to localize to Golgi membranes within tran-
siently transfected COS-1 cells, suggesting that this domain contributes to SidD localization
[25]. In this study, we present the crystal structures of both the CTD and full length SidD and
reveal how the CTDmediates membrane targeting of SidD, a process that we find here to be
critical for the protein’s ability to deAMPylate its target during infection.
Results
Crystal structure of SidD and its CTD
To investigate the function of the SidD CTD at a molecular level, we initiated the structural
characterization of the full-length protein by X-ray crystallography. Crystals that diffracted to
3.6 Å were obtained with a slightly truncated variant comprised of residues 37–507 (SidD37-
507). At this stage, crystal derivatization using heavy-atom soaking procedures or isomorphous
replacement by SeMet yielded very poor diffraction data. Further attempts at finding a molec-
ular replacement solution using the structure of the SidD37-350 catalytic domain (PDB ID code
4IIP) as a search model provided a clear solution with 6 molecules per asymmetric unit that
showed partial-difference electron density for the remaining C-terminal region of SidD. How-
ever, the lack of high-resolution data precluded the iterative refinement and model-building
steps required to interpret the structural information. Thus, we focused on obtaining a higher-
resolution crystal structure of the CTD alone. The construct encompassing amino acids 350–
507 (SidD350-507) crystallized readily and diffracted well. The structure was solved by single-
wavelength anomalous diffraction using selenium as the anomalous scatterer. The model was
refined to a resolution of 2.5 Å (Rwork 26.4%, Rfree 28.7%) with good stereochemistry. Residues
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350–367 and residues 496–507 have been excluded from the final model as they were located
in areas of poor-quality electron density and were most likely disordered. The statistics for
data collection and refinement are summarized in S1 Table.
The structure of SidD350-507 revealed a compact helical domain where a central helix (ċ9)
forms the hydrophobic core that is surrounded by five helices that are tilted with respect to the
central one and form an antiparallel bundle (Fig 1A). The numbering of secondary structure
elements (helices, loops) within the CTD is a continuation of the nomenclature previously
introduced for the N-terminal domain of SidD [25]. Despite extensive in silico analyses, we
were able to only find domains or regions with weak structural homology to SidD350-507 (for
details see Supporting Material and S9 Fig to S13 Fig). Automated ion placement in PHENIX.
REFINE identified a hexa-coordinated Mg2+ with the classical octahedral geometry formed by
the OĎ atoms of T417, T421, the main chain carbonyl oxygens of L411, V412, and D414, and
one water molecule (Fig 1B). In addition, upon closer inspection of this region we found a sec-
ond metal ion, which despite not having a recognizable coordination shell, was identified as
Zn2+ based on the clear Zn peaks in anomalous difference Fourier maps from data collected at
the zinc edge (Fig 1B and S1 Fig). Given their selective retention during protein production in
and purification from E. coli, we cannot exclude the possibility that they contribute to struc-
tural stability of SidD or possibly even a yet undefined catalytic activity (see Supplementary
Information).
With the 2.5 Å resolution structure of SidD350-507 on hand, we used each of the individ-
ual structures (SidD37-350, PDB ID code 4IIP and SidD350-507, current work) as separate
ensembles for the molecular replacement-based solution of the aforementioned 3.6 Å
SidD37-507 structure. Residues 85–88, 269–276, 365–382 and 495–507 were not well-defined
in the electron density map and could not be modeled. A summary of the data collection
and refinement statistics is given in S1 Table. The six SidD37-507 molecules present in the
asymmetric unit displayed identical structures with an L-like shape formed by two domains
in nearly perpendicular orientation (Fig 1C). We used small-angle X-ray scattering (SAXS)
to evaluate the overall structure of SidD in solution. The ab initio molecular envelope calcu-
lated from the SAXS data revealed a similar L-shaped structure but with a maximum diame-
ter Dmax of 115 Å, which differed from the calculated value of 89.2 Å for the crystal
structure. Indeed, the SidD37-507 crystallographic structure exhibited a low fit with the
observed solution scattering curve (ġ2 = 2.48) supporting the hypothesis of interdomain
flexibility (Fig 2A and 2B). Given that the scattering curve might represent the average of a
mixture of conformations coexisting in solution, we explored this possibility by multi-state
modeling with SAXS profiles (MultiFoXS) [26]. This approach allowed the deconvolution
of the scattering pattern of SidD37-507 into two subsets of conformations that best repro-
duced the SAXS profile. A superposition of these structures through the CTD showed sig-
nificant tumbling of the N-terminal deAMPylase domain, suggesting that SidD is not a
rigid molecule (Fig 2C and 2D).
An exposed hydrophobic loop mediates membrane association of SidD
We previously found that the CTD is responsible for the localization of exogenously produced
GFP-SidD to the perinuclear region, primarily membranes of the Golgi [25]. The molecular
mechanism by which the CTD recognizes and binds to Golgi membranes, but not to other cell
organelles, has remained unclear. Unlike many other L. pneumophila effectors, purified SidD
showed no binding to phospholipids [25] (S2 Fig), suggesting the existence of a different mode
of membrane targeting. Upon closer examination of the CTD sequence, we noticed a stretch
of hydrophobic residues between helices ċ7 and ċ8 (370-FLGIYGFFT-378; loopCTD) that was
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Fig 1. Crystal structure of SidD. (A) Crystallographic structure of the CTD of SidD, residues 350–507, shown in cartoon ribbon format in three orthogonal
orientations. Nomenclature for helices continues the layout previously described for the N-terminal domain of SidD [25]. The zinc and magnesium ions are represented
as grey and green spheres, respectively. (B) Final electron density map (2Fobs-Fcalc contoured at 1.5!, blue mesh) within the area of the two metal ions showing the
coordination sphere of the magnesium ion. (C) Crystallographic structure of SidD, residues 37–507, shown in cartoon ribbon format in two orientations. The N-
terminal domain (NTD) is colored in slate and the CTD in yellow.
https://doi.org/10.1371/journal.ppat.1008734.g001
Fig 2. SAXS-derived conformational assemblies of SidD37-507. (A) Comparison of the experimental SAXS profile (blue circles) along the computed scattering from
the crystallographic structure (grey line) and the profile calculated from the multi-state model obtained by the programMultiFox (orange line). The SAXS patterns are
displayed as the logarithm of the scattering intensity (I) versus the momentum transfer (s). Inset: plot of the pair distance distribution function P(r). (B) Overlay of the
DAMMIF-derived ab initio shape envelope with the crystal structure of SidD37-507. (C) MultiFoXS analyses of SidD37-507 SAXS data shows that two conformation
ensembles are present in solution as seen from the radius of gyration (Rg) distribution. Cartoons represent the two selected conformers by MultiFoXS and their
contribution percentage. (D) Superposition of the twoMultiFoXS-selected conformers of SidD37-507 through their C-terminal domains (yellow) showing a large
interdomain movement. The N-terminal domains are colored in green and slate for the conformers with 24% and 76% contribution, respectively.
https://doi.org/10.1371/journal.ppat.1008734.g002
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unstructured in the crystal structure of SidD37-507, indicative of intrinsic flexibility, and that
could constitute a potential membrane anchor for SidD (Fig 3A).
To confirm the importance of loopCTD for SidD membrane association within mamma-
lian cells, a loopCTD deletion mutant (GFP-CTDïloop) was generated, and its localization
was determined in transiently transfected COS-1 cells (Fig 3B and 3C). In comparison to
GFP-tagged CTD which showed the aforementioned co-localization with the Golgi marker
giantin [25], GFP-CTDïloop failed to localize to the perinuclear Golgi region and, instead,
displayed a cytosolic distribution pattern similar to that of GFP (control). To further under-
stand the molecular details of how the loopCTD mediates membrane association, we studied
the importance of individual amino acids for this process. Notably, four of the nine loopCTD
residues had bulky aromatic side chains (underlined in 370-FLGIYGFFT-378) (Fig 3A)
capable of associating with lipid bilayers by inserting into their hydrophobic core made
from hydrocarbon tails. While phenylalanine tends to deeply penetrate into the hydropho-
bic core of membranes, tyrosine and tryptophan assumes a saddle-like distribution prefer-
entially at the lipid-water interface [27, 28]. Sequence alignment between SidD from L.
pneumophila and its only two other known homologs from L. rowbothamii (Lr) and L. bel-
liardensis (Lb) revealed that the hydrophobic character of the loop is conserved in all three
of them (Fig 3A).
To test if the aromatic residues F370, Y374, F376, and F377 within loopCTD play a role for
CTDmembrane binding, we replaced each of them individually with either alanine (a small
nonpolar residue), serine (a polar residue), or a related aromatic residue (tyrosine with phenyl-
alanine or vice versa), and determined the localization of these SidD variants in transiently
transfected COS-1 cells by fluorescence microscopy (Fig 3D and 3E). We found that substitu-
tion of F370, F376, or F377 with either alanine or serine severely disturbed Golgi localization
of the mutant proteins and rendered them predominantly cytosolic. A more conservative
replacement of F370, F376, or F377 with tyrosine, on the other hand, had no noticeable effect
on the proteins’ Golgi targeting capabilities, emphasizing the critical importance of an aro-
matic residue at these three positions (Fig 3D and 3E). In contrast, Y374 was dispensable for
membrane binding, and its substitution with phenylalanine, alanine, or even serine had no
effect on Golgi targeting of GFP-CTD (Fig 3D and 3E). Overall, these results demonstrated
that the hydrophobic loop within the CTD of SidD functions as membrane-targeting determi-
nant, and that residues with bulky hydrophobic side chains at positions 370, 376, and 377 are
crucial for membrane binding.
To further confirm the contribution of the loopCTD to membrane binding, we studied the
association of purified recombinant SidD37-507 or SidDïloop with synthetic membranes in a
co-flotation assay (Fig 4A). Upon sucrose gradient centrifugation, the majority of SidD37-507
was detected in the liposome-containing fraction, whereas SidDïloop was undetectable (Fig
4B). Notably, upon cryo-electron microscopy analysis, liposomes that were incubated with
SidD37-507 appeared fully decorated by SidD37-507, whereas liposomes that were incubated with
SidDïloop showed a clean bilayer as did control liposomes (Fig 4C). Finally, using surface plas-
mon resonance spectroscopy (SPR), we demonstrated a specific SidD-membrane interaction
which yielded a dissociation constant of 4.4 "M, whilst SidDïloop, as expected, exhibited no
detectable binding (S3 Fig). Importantly, circular dichroism and SAXS measurements showed
that the deletion of the hydrophobic loop of SidD neither affected the structure of SidD, nor
significantly altered the interdomain flexibility (S4 Fig). Together, these results demonstrate
that the hydrophobic loopCTD plays an integral role for association of SidD with biological
membranes.
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Fig 3. A hydrophobic loop within the CTD is required for SidD localization. (A) Schematic representation of the position and composition of the loopCTD and
alignment with SidD homologs from L. rowbothamii (Lr) and L. belliardensis (Lb). Hydrophobic residues within the loop region are colored in red. NTD, N-terminal
domain; CTD, C-terminal domain. Numbers indicate amino acid positions. (B) Intracellular localization of CTD variants. Transiently transfected COS-1 cells
producing either GFP (control) or GFP-CTD variants were fixed and stained using an antibody directed against the Golgi marker protein giantin (middle). Merged
images show SidD proteins in green and giantin in red. Scale bar, 10 "m. Line scans (right) indicate pixel intensity of the green (GFP) and red (giantin) fluorescent
signals along the dashed lines (distance in "m). (C) Quantification of (B) showing percentage of cells with SidD enrichment at the Golgi compartment. Numbers are
results from at least 100 cells per sample and experiment. The graph represents the average of three biological replicates. (D) Effect of aromatic residue substitutions on
intracellular localization of the CTD. Transiently transfected COS-1 cells producing either GFP (control, see panel B) or the indicated GFP-CTDmutants were
chemically fixed, and stained for giantin to label the Golgi. The localization of CTD was evaluated by fluorescence microscopy. Amino acid substitutions at position
F370, Y374, F376, and F377 were as follows: alanine (A), serine (S), tyrosine (Y), phenylalanine (F). Scale bar, 10 "m. (E) Quantification of (D) scoring cells with
colocalization of GFP-CTD and giantin. The graph represents the average of at least 100 transfected cells from three biological replicates.
https://doi.org/10.1371/journal.ppat.1008734.g003
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A carboxyl-terminal pair of ċ-helices determines Golgi specificity of SidD
While hydrophobic interactions can significantly contribute to membrane anchoring of pro-
teins, they provide little selectivity for a particular membrane compartment or organelle.
Given the preference of exogenously produced GFP-SidD for Golgi membranes, we
Fig 4. The hydrophobic loop is crucial for liposome binding of SidD during liposome flotation. (A) Illustration of the liposome flotation
assay (left). (B) Coomassie blue-stained SDS-PAGE gel showing the binding of recombinant SidD37-507, but not SidDïloop, to free liposomes.
(C) Representative cryo-EM images of a control liposome (left), a liposome incubated with SidD37-507 (middle), and a liposome incubated
with SidDïloop (right). Scale bar, 50 nm. The plot below each image represents the corresponding cross-sectional electron density profile
along the perimeter of the liposome.
https://doi.org/10.1371/journal.ppat.1008734.g004
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hypothesized that the CTD, in addition to the aforementioned membrane-targeting determi-
nant (loopCTD), contained a specificity determinant that mediated preferential Golgi localiza-
tion. One feature within the CTD that could constitute such a membrane specificity
determinant were two patches of charged residues; a positively charged patch composed of res-
idues K416 and K433 adjacent to the loopCTD, and a negatively charged patch containing
D464 and E467 in helix ċ12 (S5A Fig). Electrostatic interactions often provide selectivity to a
protein’s membrane localization and orientation by pairing with oppositely-charged lipid
head groups, thus favoring interaction with specific types of membranes [29, 30]. To test if the
charged patches near the loopCTD were responsible for SidD’s preference for Golgi mem-
branes, we performed charge inversion through site-directed mutagenesis, replacing either
K416 and K433 with glutamates (KK/EE) or D464 and E467 with arginine residues (DE/RR).
The localization of these GFP-tagged CTDmutants was examined in transiently transfected
COS-1 cells. Notably, charge inversion had no noticeable effect on the extent to which the sig-
nal of either GFP-CTD(KK/EE) or GFP-CTD(DE/RR) overlapped with that of the Golgi
marker giantin (Fig 5A, S5B Fig), suggesting that neither of the two charged patches made any
major contribution to the enrichment of SidD on Golgi membranes or to the protein’s general
membrane binding capacity.
Next, we systematically shortened SidD-CTD from its C-terminal end (Fig 5A) and deter-
mined the localization pattern of these truncated variants in transiently transfected COS-1
cells in order to identify a possible membrane specificity determinant. Despite containing the
complete loopCTD region, the CTD variants ending at position 387, 406, or 435, showed a cyto-
solic distribution pattern similar to GFP (Fig 5C), suggesting that they no longer bound to
membranes, most likely because of folding or stability issues. In contrast, CTD(322–450),
which lacked the carboxy-terminal two alpha-helices, ċ12 and ċ13 (Fig 5B), still associated
with cellular membranes (Fig 5C, S6A Fig). Interestingly, in addition to its enrichment on
Golgi membranes, CTD(322–450) was also found on other membrane compartments, includ-
ing tubular organelles, that did not stain positive for giantin, suggesting that these membranes
were not the Golgi. Upon co-production of GFP-tagged CTD(322–450) with a variety of orga-
nellar markers in transiently transfected COS-1 cells, we detected a substantial colocalization
between CTD(322–450) and the mitochondria marker Mito-RFP (Mito-red fluorescence pro-
tein) (Fig 5D). These results suggested that the C-terminal two alpha-helices (ċ12 and ċ13)
that are missing in CTD(322–450) were responsible for the selective enrichment of SidD on
membranes of the Golgi, while the loopCTD functioned as general membrane anchor that is
insufficient to distinguish lipid bilayers of different composition. Consistent with this model,
we found that substitution of F370, one of the residues critical for loopCTD membrane binding
(Fig 3D), with serine resulted in the failure of CTD(322–450; F370S) to associate with either
Golgi or mitochondria membranes (Fig 5C and 5D and S6A Fig). Similar results were obtained
in transiently transfected Hela cells, both by microscopy and subcellular fractionation, where
F370S substitution rendered CTD(322–450) mostly cytosolic (S6 Fig). Taken together, our
data revealed that the CTDmediates localization of SidD to membranes using a dual-binding
mode that combines a general membrane-binding determinant in form of the loopCTD with a
specificity determinant represented by a helix-turn-helix unit at the C-terminus.
Despite extensive efforts using a variety of protein-protein interaction approaches, we were
unable to identify any proteinaceous host cell factor that stably interacted with CTD. Since
lipid-protein overlay assays had already excluded charged phospholipids as possible SidD
ligands [25] (S2 Fig), we performed sequence alignment among the known SidD homologs
and identified five conserved residues within the C-terminal two-helix bundle (L469, K472,
D484, I485, L491) that are surface-exposed and available to aide in possible ligand interaction.
Site-directed mutagenesis of a cluster of four of these residues, either individually or
PLOS PATHOGENS Membrane targeting of SidD
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combined, had no obvious effect on Golgi localization of CTD within transiently transfected
cells (S7 Fig), suggesting that membrane selectivity may involve interactions through addi-
tional CTD residues.
SidD localizes to the surface of Legionella vacuoles
A L. pneumophila ïsidDmutant is defective for the timely removal of Rab1 from LCVs [23,
24], suggesting that during infection the surface of the LCVs is a site of SidD function. None-
theless, earlier efforts to detect translocated SidD on LCVs by immunofluorescence micros-
copy have been unsuccessful [23, 24], most likely because the levels of endogenously produced
SidD were below the detection limit. To experimentally confirm the selectivity of SidD for
LCVmembranes, we exogenously produced GFP-tagged CTD, CTDïloop, or CTD(322–450)
in transiently transfected COS-1 cells and then challenged these cells with L. pneumophila. If
LCV membranes can be recognized by the CTD, then GFP-tagged SidD should localize to the
surface of these compartments. To reduce possible interference by endogenously produced
SidD, a L. pneumophila ïsidD strain was used for these studies, while the T4SS-deficient
mutant strain (Lp03) that cannot establish a replication compartment and, instead, is delivered
to lysosomes, was included as control (Fig 6). While GFP-CTD accumulated as a ring-shaped
green halo about LCVs containing L. pneumophila ïsidD but not LCVs containing the aviru-
lent strain Lp03 (Fig 6), no enrichment of GFP-CTDïloop was observed around either type of
LCV (Fig 6), showing that SidD has the capacity to recognize and bind to LCVmembranes
containing virulent L. pneumophila in a process that requires the loopCTD as membrane bind-
ing determinant. Notably, despite its ability to associate with host membranes, GFP-CTD
(322–450) failed to accumulate on LCVs (Fig 6), suggesting that the C-terminal ċ-helix bundle
determines membrane specificity of SidD during Legionella infection.
Localization to Legionella vacuoles is critical for SidD function during
infection
With the newly acquired ability to disturb SidD membrane binding, we set out to address
another important question—whether membrane localization is required for the function of
SidD during infection. Earlier studies revealed that failure of L. pneumophila to deAMPylate
Rab1 results in a prolonged colocalization of Rab1 with LCVs [23–25]. This kinetic defect in
Rab1 removal resulted from the inability of AMPylated Rab1 to be efficiently deactivated by
the Rab1 GAP LepB. Due to the lack of molecular probes capable of directly binding to and
visualizing AMPylated Rab1within cells, monitoring Rab1 dynamics has been used as a surro-
gate assay for examining the Rab1 AMPylation status and, thus, the activity of SidD [23–25].
To investigate the importance of the loopCTD for the biological function of SidD during L.
pneumophila infection, the dynamics of Rab1 was analyzed in bone marrow-derived A/J
mouse macrophages infected with L. pneumophila containing a chromosomal copy of either
sidD (strain Lp02), ïsidD, or sidDïloop. Consistent with our earlier findings [25], Rab1
Fig 5. The carboxy-terminal helix bundle determines localization specificity. (A) Schematic representation of CTD and its variants. Numbers indicate
amino acid positions; asterisks represent residues altered by site-directed mutagenesis. The hydrophobic loop is shown in grey, and the region required for
specific localization of CTD to Golgi membranes is highlighted in green. The intracellular localization of each CTDmutant (as shown in (C)) is summarized
on the right. (B) Ribbon diagram of SidD-CTD (aa 322–450) colored in orange and the C-terminal helix-turn-helix bundle is colored in green. The relative
position of the deAMPylation domain is shown in transparent slate. (C) Intracellular localization of CTD variants. Transiently transfected COS-1 cells
producing the indicated GFP-CTD proteins (left) were chemically fixed and stained for giantin (middle). The localization of SidD relative to giantin is shown
on the right. Scale bar, 10 "m. (D) Localization of CTD(322–450) to mitochondria membranes. Transiently transfected COS-1 cells coproducing GFP-CTD
(322–450) or GFP-CTD(322–450; F370S) and Mito-RFP (a mitochondria marker) were chemically fixed, and the fluorescence signal was examined by
confocal microscopy. Arrowheads indicate the position of membranes magnified in the insets. Scale bar, 10 "m.
https://doi.org/10.1371/journal.ppat.1008734.g005
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colocalized with Lp02-containing LCVs early but not late during infection (49±1% positive at
2 h, 28±3% at 4 h and 15±1% at 6 h) (Fig 7A), whereas LCVs containing Lp02ïsidD showed a
prolonged colocalization with Rab1 compared to Lp02 (52±2% vs 15±1%) at 6 h after bacterial
uptake (Fig 7B). Similar to Lp02ïsidD, vacuoles containing Lp02sidDïloop showed a pro-
nounced delay in Rab1 removal from LCVmembrane 4 h post infection compared to Lp02
(62% vs 28%) (Fig 7B). Rab1 removal deficiencies were even more evident 6 h post infection
for Lp02sidDïloop, with 49% LCV staining positive for Rab1 compared to only 15% for Lp02
(Fig 7A and 7B). A similar defect in Rab1 removal was observed in bone marrow-derived mac-
rophages challenged with Lp02sidD(D92A), a strain that produced a deAMPylation-inactive
protein and that is known to exhibit prolonged Rab1 retention [25] (Fig 7B). Immunoblot
analyses confirmed that production of SidDïloop had no effect on the expression level of sidM
in L. pneumophila (S8A Fig). A beta-lactamase reporter-based translocation assay also verified
that the deletion of the loop did not interfere with the delivery of SidDïloop during infection
(S8B Fig). The finding that a SidDïloop variant phenocopied the Rab1 removal deficiency of
the deAMPylation defective variant SidD(D92A) indicates that membrane association via the
loopCTD was of critical importance for SidD to perform its biological function, namely the
deAMPylation of Rab1 surrounding Legionella vacuoles.
Discussion
In this study, we provided insight into the structure and function of the L. pneumophila effec-
tor SidD, the first and thus far only known translocated effector to exhibit deAMPylation activ-
ity, and discovered an important role for the CTD as a membrane targeting module.
Fig 6. SidD localizes to LCVs via its loopCTD. (A) GFP-CTD localizes to the surface of LCVs. Transiently transfected COS-1 cells producing indicated GFP-CTD
variants were challenged with L. pneumophila for 2 hours. Intracellular bacteria were labeled using anti-Legionella-specific antibody followed by TexRed-conjugated
secondary antibody. GFP-CTD localization was examined by fluorescence microscopy. White arrowheads indicate the position of bacteria magnified in the insets. Scale
bar, 10 "m. (B) Quantification of (A) scoring SidD-decorated LCVs. Values are an average of at least 50 LCV compartments from three experimental replicates.
https://doi.org/10.1371/journal.ppat.1008734.g006
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By solving the crystal structure of SidD37-507, we discovered that the protein assumed an L-
like shape within the crystal lattice. The N-terminal deAMPylase domain possesses a protein
phosphatase fold, while the CTD is formed by a bundle of anti-parallel alpha-helices with no
apparent similarity to known structures (Fig 1A). The two domains are connected via a flexible
linker and are positioned almost perpendicular to each other in the crystal lattice (Fig 1C).
Our SAXS analyses subsequently revealed a relative mobility between the two domains, with
76% of the particles existing as L-shaped molecules in solution while the other 24% of the par-
ticles assumed a more extended morphology (Fig 2C). If and how this interdomain flexibility
between the two domains is regulated is currently unclear, but it could facilitate the recogni-
tion of AMPylated Rab1 during infection. Rab1 is connected to membranes via its ~25 amino
acid long flexible C-terminal linker termed the hypervariable domain which allows the GTPase
domain to be elevated 100Å or more above the lipid bilayer [31, 32]. Having a high degree of
flexibility between the catalytic domain and the localization domain could increase the sam-
pling radius of membrane bound SidD from a two-dimensional plane to a three-dimensional
space (S1 Video).
A notable feature within the CTD that caught our attention was the loopCTD (region
370-FLGIYGFFT-378), which is conserved among SidD homologs (Fig 3A) and critical for
membrane binding of L. pneumophila SidD (Figs 3 and 4). Deletion of the loopCTD strongly
attenuate the ability of SidD to associate with membranes both in vitro (Fig 4) and within cells
Fig 7. Membrane association of SidD is critical for Rab1 deAMPylation. (A) Rab1 dynamics on the LCV surface. Bone marrowmacrophages challenged with the
indicated L. pneumophila strains were chemically fixed at the indicated time points. Rab1 was detected by indirect immunolabeling using a Rab1B-specific antibody
followed by secondary Alexa Fluor 488-conjugated antibody. L. pneumophila was stained with anti-Legionella-specific antibody and TexRed-conjugated secondary
antibody. Cells were examined by confocal microscopy showing L. pneumophila in red and Rab1 in green. Scale bar, 1 "m. (B) Quantification of LCVs decorated with
Rab1 analyzed under (A). At least 100 LCVs were counted per sample to determine the percentage of LCVs decorated with Rab1. The graph shows the average of
three independent replications. ⇤⇤⇤P<0.001, ⇤⇤P<0.01.
https://doi.org/10.1371/journal.ppat.1008734.g007
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(Fig 3B). Moreover, substitution of any of the three phenylalanine residues at position 370,
376, or 377 with small or non-hydrophobic residue (alanine or serine) abolished the ability of
GFP-CTD to robustly localize to the Golgi apparatus in transiently transfected COS-1 cells
(Fig 3D and 3E), indicating that large hydrophobic side chains play a critical role for anchoring
SidD to membranes. There are a wide variety of strategies used by bacterial effector proteins to
associate with membranes [33], ranging from transmembrane domains (YlfA/LegC7 and
YlfB/LegC2) [34], membrane curvature-sensing domains (L. pneumophila RavZ) [35] and
phosphoinositide binding domains (SidM, SidC, LidA, RavD, or RavZ to name a few) [35–40]
to host-mediated ubiquitination (Salmonella SopB) [41] and lipidation (farnesylation, gerany-
lation, S-palmitoylation) [42–45]. The loopCTD of SidD is much shorter than a typical trans-
membrane domain (~20 residues long) and, thus, unlikely to cross the entire lipid bilayer.
Instead, our data suggest that the loop might form an amphipathic helix or segment that
inserts laterally into membranes, with F370, F376, and F377 being buried within the hydro-
phobic core made from the lipids’ hydrocarbon chains. Replacement of either one of these ali-
phatic phenylalanines by tyrosine did not noticeably affect Golgi localization of the CTD,
showing that the amphipathic nature of tyrosines was tolerated at those positions, probably
because their hydroxyl group was facing out of the lipid bilayer towards the polar head groups.
Serine residues, on the other hand, were not tolerated at amino acid positions 370, 376, and
377 likely due to their hydrophilic character, and neither were alanine residues which may not
penetrate the membrane deep enough in order to provide sufficient adhesion. Short stretches
of hydrophobic residues have previously been found to function as membrane localization
domains in several bacterial effectors, including ExoS and ExoT (both Pseudomonas aerugi-
nosa), YopE (Yersinia pseudotuberculosis), and SopB (Salmonella) (reviewed in [46]). The ~22
residue long leucine-rich membrane localization region in ExoS, ExoT, and YopE is predicted
to form an amphipathic helix, with charged residues clustered on one side, hydrophobic resi-
dues on the opposite face of the helix. In ExoS, substitution of the conserved leucine residues
with asparagine phenocopied the membrane targeting defect of a deletion mutant lacking the
entire membrane localization domain, whereas substitutions of charged residues abolished
plasma membrane localization but not perinuclear localization of ExoS [47, 48]. Thus, like
ExoS, SidD relies on the combined effort of a membrane binding determinant and a specificity
determinant for intracellular targeting.
Not surprisingly, deletion of the membrane localization domain from ExoS or YopE limited
the ability of P. aeruginosa to efficiently ADP-ribosylate host cell Ras GTPases or of Y. pseudo-
tuberculosis to exhibit maximum virulence [47, 49]. In macrophages infected with L. pneumo-
phila, we made a similar observation where a mutant strain producing SidDïloop displayed the
same kinetic defect in Rab1 removal from LCVs as a ïsidD strain, demonstrating that proper
membrane binding of SidD was critical for its function and that failure to stably associate with
LCVs interfered with the ability of SidD to efficiently deAMPylate Rab1 prior to its removal
(Fig 7). Our earlier studies already hinted at the importance of membrane binding for the
function of SidD, where the cytotoxicity of SidM overproduction in transiently transfected
COS-1 cells was counteracted by full-length SidD but not by truncated SidD lacking the CTD
membrane-targeting domain [25]. We also confirmed that exogenously produced GFP-CTD,
but not GFP-CTDïloop targeted to LCVs of virulent L. pneumophila but not to those of the
T4SS-defective mutant Lp03 which is delivered to lysosomes (Fig 6), indicating that SidD can
distinguish different types of vacuolar membranes.
During infection, the vacuole containing virulent L. pneumophila is gradually converted
into an ER-like compartment that evades endolysosomal fusion [14, 50]. Part of that transfor-
mation process is the acquisition of certain phospholipids such as PI(4)P and the removal of
others (PI(3)P) [51]. Several L. pneumophila effectors have been shown to directly modify
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phosphoinositides, including the effector LepB (phosphatidylinositide 4-kinase), SidF (phos-
phoinositide phosphatase), or SidP (phosphoinositide phosphatase) [52–54]. Other effectors
such as SidM and SidC possess phosphoinositide-specific binding domains for stable associa-
tion with the membrane of the LCV or surrounding organelles [37, 38, 51, 55, 56]. Although
SidD did not stably interact with phospholipids in vitro [25], the finding that it localizes to
LCVs during infection or Golgi membranes in transiently transfected cells, both organelles
that contain PI(4)P, suggests that this phospholipid and/or a protein common to both com-
partments could contribute to the selectivity of SidD for these membranes. The fact that vacu-
oles containing Lp03 do not maintain a stable pool of PI(4)P may explain why they failed to
attract GFP-CTD (Fig 6).
By producing truncated CTD variants in transiently transfected COS-1 cells, we discovered
that the selectivity of SidD for specific membranes required a C-terminal helix-loop-helix
motif (residues 451–507) of the CTD, and that deletion of ċ12 and ċ13 resulted in the failure
of CTD(322–450) to selectively target the Golgi (in transiently transfected cells) (Fig 5) or the
LCV (during infection) (Fig 6). Instead, the protein localized to organelles other than the
Golgi, including mitochondria (Fig 5D). We hypothesize that the ċ12 and ċ13 bundle forms
an interaction platform for a yet-to-be determined host cell ligand that is enriched on the LCV
during infection (Fig 6) or the Golgi within transiently transfected cells (Fig 5), and that dele-
tion of this platform causes SidD to indiscriminately insert into membranes via its hydropho-
bic loop. While the host ligand that directs the CTD to specific membranes awaits
identification, our data provide evidence for a previously unknown dual mode mechanism for
membrane targeting by a L. pneumophila effector, where the combined action of a general
membrane-binding determinant and a specificity determinant directs SidD to a particular
type of membrane. We speculate that this dual targeting mode allows proper SidD localization
within a wide variety of amoebal species that the bacterium encounters in its natural freshwa-
ter habitat, thus providing the organism with a fitness advantage. Future studies will reveal if
additional effectors from L. pneumophila or related pathogens use a similar targeting strategy
within host cells.
Materials andmethods
Strains, plasmids, and reagents
All Legionella strains are derivatives of Legionella pneumophila Philadelphia-1 Lp02 (thyA,
hsdR, rpsL) [57]. Lp03 is a T4SS-defective strain variant with a mutation in dotA [57], while
Lp02sidD(D92A) encodes a deAMPylation-deficient mutant form of SidD [25]. Lp02sidDïloop
has a chromosomal sidD allele with a deletion of the sequence encoding amino acids 370 to
378. L. pneumophila was cultured in liquid AYE medium or maintained on solid CYET plates
as described before [58].
Plasmids and oligonucleotides used in this work are summarized in S2 Table and S3 Table,
respectively. pNPTS138D-sidDflank was generated by subcloning a fragment ranging from
336bp upstream to 482bp downstream of sidD into pNPTS138D via Gateway cloning.
pNPTS138D-sidDïloop was constructed using Quickchange site-directed mutagenesis (Agilent
Technologies) with 5’sidD_del370-378 and 3’sidD_del370-378 as primers and pNPTS138D-
sidDflank as template. pGEX-6P-1-SidD-CTD was constructed by subcloning the sidD(322–
507) fragment into the BamHI and SalI restriction sites of pGEX-6P-1. pEGFP-CTD(322–507)
was previously described [25]. Plasmids encoding GFP-tagged SidD-CTD variants and C-ter-
minal truncations were generated by QuickChange site-directed mutagenesis using the indi-
cated primers (S3 Table) and pEGFP-SidD-CTD as template. SidD37-507 and SidD350-507 were
cloned into the bacterial expression vector pHis-Parallel2 using NdeI-BamHI and BamHI-
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NcoI as restriction sites and adding 5 or 6 histidines tag at the C-terminus respectively. pHis-
Parallel2-SidDïloop was constructed by Gibson assembly using pHis-Parallel2-SidD37-507 as
template and the primes SidDïloop-up, SidDïloop-low, Amp-up and Ampi-low. The Clon-
tech Mito-RFP plasmid was a gift from Richard Youle (National Institute of Neurological Dis-
orders and Stroke, National Institutes of Health, Bethesda, MD). Plasmids were introduced
into L. pneumophila by natural transformation [59]. E. coli was grown in Luria-Bertani (LB)
broth with antibiotics (30 "g/ml Kanamycin, 100 "g/ml Ampicilin or 100 "g/ml Chloram-
phenicol) where necessary.
Antibodies were purchased from Santa Cruz Biotechnology (Rab1B), Abcam (giantin) and
Thermo Fisher Scientific (fluorophore-conjugated secondary antibodies). Antibody against L.
pneumophila was generated in rat using formalin-killed bacteria as described before [24].
Anti-SidM antibody were described previously [21].
Cell lines and immunofluorescence microscopy
COS-1 and Hela cells were grown in Dulbecco’s modified minimum Eagles’s medium
(DMEM) supplemented with 10% FBS and incubated at 37˚C in 5% CO2. Bone marrow-
derived macrophages (BMMs) were isolated from the femurs of female A/J mice and differen-
tiated in RPMI-1640 containing 20% FBS, 1.6 mM glutamine, 30% L-cell culture medium, and
penicillin (10,000 IU/ml) and streptomycin (10 mg/ml) for one week as previously described
[60].
COS-1 or Hela cells grown in 24-well plates were transfected with plasmids encoding EGFP
fused SidD variants using Lipofectamine1 2000 (Life Technologies, Inc.). After overnight
incubation, cells were fixed with 3.8% formaldehyde, permeabilized with cold methanol,
blocked with 1% BSA and stained with anti-giantin antibody at a dilution of 1:3000. Coverslips
were mounted with Prolong1 Gold antifade reagent (Thermo Fisher Scientific) and imaged
with a Zeiss Axio Observer Z1 inverted microscope or Zeiss LSM800 confocal microscope.
For transfection-infection assays, COS-1 transfected with plasmids encoding GFP-tagged
SidD variants were challenged with the indicated L. pneumophila strains at an MOI = 50, and
spun at 200g for 5 min to enhance bacteria-cell contact. After 1 h, the cell monolayers were
washed three times with warm DMEM to remove extracellular bacteria and incubated in
DMEM for another 1 h. The cell monolayers were chemically fixed with 3.8% formaldehyde.
Cells were permeabilized with cold methanol, blocked with 1% BSA, and stained for outside
bacteria using rat anti-Legionella antibody and goat anti-rat Alexa Fluor355-conjugated anti-
body while intracellular bacteria were labeled with goat anti-rat Alexa TexRed-conjugated
antibody.
BMMs were challenged with the indicated L. pneumophila strains at an MOI = 5, fixed with
3.8% formaldehyde at the indicated time points, and stained for extracellular and intracellular
bacteria as described above. The presence of Rab1 on LCVmembranes was determined using
protein-specific antibody and goat anti-rabbit Alexa Fluor 488-conjugated antibody. Images
were taken on a Zeiss LSM800 confocal microscope with Airyscan.
Protein production and purification
Recombinant proteins for structural analyses were produced in E. coli BL21(DE3) (Stratagene)
and purified similarly to previously described methods [25]. Briefly, cells were grown in LB
medium to an OD600 of 0.8, protein production was induced with 1 mM isopropyl-Č-dithioga-
lactopiranoside (IPTG) at 20˚C overnight. Cells were harvested by centrifugation, resuspended
in TBS (150 mMNaCl, 50 mM Tris-HCl, pH 7.4 supplemented with 5 mM imidazole, 10 mM
Č-mercaptoethanol (BME)) and lysed at 4˚C by high pressure homogenization (27 Kpsi;
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Constant System Ltd). All subsequent purification steps were carried out at 4˚C. Insoluble
material was removed by ultracentrifugation, and His-tagged proteins were purified by affinity
chromatography using 10 ml of Ni-NTA beads (QIAGEN) packed in a gravity column. After
extensive washing with the same loading buffer, proteins were eluted by addition of 200 mM
imidazole and dialyzed in 25 mMNaCl, 10 mM BME and 50 mM Tris-HCl pH 8.5 buffer.
Tobacco etch virus (TEV) protease was included in a 1/20 protease/protein ratio during the
overnight dialysis to cleave the His-tag. The protein solution was loaded onto an ion exchange
chromatography column (HiTrap Q HP; 5 ml; GE Healthcare) followed by an isocratic gradi-
ent from 0.025 M to 1 M NaCl in 20 column volumes. Fractions containing SidD37-507 or
SidD350-507 were concentrated and loaded onto a HiLoad 16/60 Superdex 200 Gel Filtration
column (GE Healthcare) or a HiLoad 16/60 Superdex 75 Gel Filtration column (GE Health-
care), respectively, that had been equilibrated with TBS supplemented with 10 mM BME. Frac-
tions containing pure protein were pooled, concentrated to 1 mg/ml and stored at -80˚C.
SidDïloop was expressed and purified as described for SidD37-507.
Selenomethionine (SeMet)-substituted SidD350-507 was produced in E. coli B834 (Strata-
gene), a methionine auxotroph strain, using SelenoMet medium (Molecular Dimensions) fol-
lowing the manufacturer’s instructions. SeMet SidD350-507 purification was carried out under
the same conditions as that of the native protein. The efficiency of SeMet incorporation was
evaluated by mass differences between native (unlabeled) and SeMet-labeled protein samples
using MALDI-TOF mass spectrometry. The observed mass differences confirmed 100% sele-
nomethionine incorporation at seven expected sites.
Crystallization, data Collection and Structure determination
Crystals of native and SeMet substituted SidD350-507 were grown by hanging drop vapor diffu-
sion at room temperature by mixing a 11 ratio of protein stock (8 mg/mL) to well solution (2.0
M NaCl, 20% glycerol, 0.1 M sodium acetate, pH 4.6). Crystals of SidD37-507 were grown by sit-
ting drop vapor diffusion at room temperature by mixing a 3:1 ratio of protein stock (10 mg/
mL) to well solution (2.88 M sodium formate, 0.1% Anapoe 35, 0.09 M Tris-HCl, pH 8.0).
Crystals of SidD350-507 appeared within one week whilst crystals of SidD37-507 appeared after
three months.
Data collection with the SidD350-507 SeMet-substituted crystal was carried on a Pilatus 6M
detector (Dectris) on the I02 beamline at Diamond Light Source (United Kingdom). Posterior
data collection at higher resolution for native SidD350-507 (2.5 Å) and for native SidD37-507 (3.6
Å) was performed on a Pilatus 6M detector (Dectris) on the PXI-X06SA MD1 beamline at
Swiss Light Source (Switzerland). All diffraction data sets were processed using the XDS pro-
gram [61]. The Se positions in SidD350-507 and the phase calculations were determined by
direct methods using AutoSharp [62]. An initial model was generated with phenix.autobuild
within the PHENIX suite [63]. The model was manually completed in Coot [64] and then
refined with PHENIX with alternating rounds of manual intervention and optimization. Data
collection and refinement statistics are shown in S1 Table.
SAXS analysis
SAXS data were collected on the BL21 beamline at the Diamond Light source (United King-
dom), using the HPLC-integrated SAXS setup with a Pilatus 2M detector over an angular
range qmin = 0.004 Å-1 to qmax = 0.37 Å-1. For SidD37-507 or SidDïloop, a volume of 45 "l at 11
mg/ml was injected into a pre-equilibrated (25 mMHEPES pH 7.5, 300 mMNaCl and 0.5
mM TCEP) Shodex KW-402.5 gel filtration column. Scattering was recorded over the course
of protein elution with a flow rate of 0.16 ml/min at 20˚C. Data averaging and reduction was
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carried out with ScÅtter (Version 3.1r by Robert P. Rambo, Diamond Light Source, UK). Fur-
ther analyses (radius of gyration; Rg, maximum distance; Dmax and particle distance distribu-
tion function; p(r) calculations) were carried out with the ATSAS suite package [65]. Low-
resolution shape envelopes for SidD37-507 were determined using the ab initio bead modelling
program DAMMIF [66]. Modelling was performed without the use of symmetry restraints.
Twenty simulations were performed, which generated similar shapes from witch an averaged
filtered structure was obtained using DAMAVER [67]. Then, this structure was refined as a
fixed input core in DAMMIN to generate a final model with 795 dummy-atoms. The resulting
bead model was converted to a map envelope and visualized using CHIMERA [68]. The pro-
gram SUPCOMB [69] was used to compare the ab initio model with the crystallographic data
whilst the program CRYSOL [70] was used to compare the 1D scattering curve with the theo-
retical scatter of SidD37-507 model. The Multifox webserver [26] was used to calculate a multi-
state model of SidD37-507 or SidDïloop in solution. The crystallographic structure was used as
input model where residues I335 to L339 where considered flexible, and then 10.000 confor-
mations were generated by the RRT (Rapid Random Trees) algorithm sampling. The top solu-
tion corresponded to a two-state model, and there was no significant improvement in the ġ2
scores for models of three or more states.
Lipid overlay assay
Lipid overlay assays were performed following the manufacturer’s instructions. Briefly, membrane
strips (Echelon Biosciences, cat# P-6001, P-6002) with spotted lipids were blocked with TBST
+ 5% BSA at room temperature for 1 h, incubated with purified SidD37-507 or SidM at room tem-
perature for 1 h, and washed with TBST three times to remove unbound protein. The membrane
strips were then incubated with anti-SidD or anti-SidM antibody, washed again with TBST three
times, followed by incubation with HRP-conjugated goat anti-rabbit secondary antibody. The
binding of protein to lipids on the membrane strips was detected by chemiluminescence.
Circular dichroism measurements
Circular dichroism (CD) measurements were carried out with a Jasco J-810 spectropolarimeter
(JASCO, Tokyo, Japan) equipped with a Peltier temperature control. CD spectra were acquired
at 25˚C with 0.2 nm data pitch, 50 nm/min scanning speed, 4 sec response, 4 nm band width
and 5 accumulations, using a 0.1 cm path length quartz cuvette. The samples were measured at
a concentration of 30 "M in 5 mMHEPES buffer pH 7.5, 75 mMNaCl and 0.5mMDTT.
Isothermal Titration Calorimetry (ITC)
SidD37-507 and Rab1-CT peptide were dialyzed overnight in 150mMNaCl, 0.5mM TCEP and
25 mMHEPES pH 7.5 at 4˚C. The compounds; N-Acetyl-S-geranyl-L-cysteine (AGC) and
N-Acetyl-S-farnesyl-L-cysteine (AFC) were dissolved in DMSO at 25 mg/ml and subsequently
diluted in the dialysis buffer. Rab1-CT peptide at 1mMwas titrated into SidD37-507 at 10 "M in
aliquots of 10 "l. AGC and AFC were titrated into SidD37-507 (10 "M) at 417 "M and 408 "M
respectively. All ITC measurements were carried out at 25˚C on a VP-ITC Microcalorimeter
(MicroCal/GE Healthcare). The ITC data were processed using Origin software (OriginLab
Corp., USA).
Liposome preparation
Liposome preparation for SPR: 1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC) dissolved
in chloroform:methanol (2:1) was dried under argon to obtain a lipid film, which was hydrated
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with 10 mMHEPES pH 7.5, 150 mMNaCl and 1 mMDTT at a final lipid concentration of 1
mM. Small unilamellar vesicles (SUVs) were prepared by vigorous vortexing of the lipid sus-
pension followed by sonication for 10 minutes with cycles of 5 second pulses in 5 second
intervals.
Liposome preparation for flotation assay: 1,2-dioleoyl-sn-glycero-3- phosphoethanolamine
(DOPE), 1,2-dioleoyl-sn-glycero-3-phospho-l-serine (DOPS), and 1,2-dioleoyl-sn-glycero-
3-phosphocholine (DOPC) in a 5:3:2 molar ratio containing 0.1% of Rhod-PE were dissolved
in chloroform:methanol (2:1) and dried under argon to obtain a lipid film. The film was re-
hydrated with flotation buffer (FB), 150 mMNaCl, 0.5 mM TCEP and 10 mMHEPES pH 7.5,
with 10% sucrose, and subjected to vortex mixing. Then 10 freeze-thaw cycles followed by
mechanical extrusion through a 0.2 "m cut-off filter were carried out until the mixture become
clear.
Liposome preparation for cryo-EM followed the same protocol as for the flotation assay but
without the inclusion of Rhod-PE and sucrose.
Liposome flotation assay
In a standard reaction, 100 "l liposomes (1 mM) were mixed with 25 "M SidD37-507 or Sid-
Dïloop in buffer FB and incubated for 15 minutes. The sample was gently mixed with a stock
solution of 80% sucrose in FB to achieve a final sucrose concentration of 30%, which was
placed at the bottom of an ultra-ClearTM tubes (Beckman Coulter, cat. 344090) and overlaid
with 600 "l buffer FB25 (25% sucrose in FB), and 100 "l buffer FB. Tubes were centrifuged at
240,000 g for 1 hour at 4˚C, and the top 30–50 "l fraction was collected and used for
SDS-PAGE analysis.
Cryo-electron microscopy analysis
Samples containing liposomes incubated with SidD37-507, SidDïloop or no protein, were loaded
on freshly glow-discharged Quantifoil R2/2 grids. Vitrification was performed on Vitrobot
Mark II (FEI Company, USA) maintained at 8˚C and at a relative humidity close to saturation
(90% rH). Five microliters of sample solutions were absorbed onto the grid for 30 seconds and
blotted with filter paper. Grids were immediately plunged into a liquid ethane bath and stored
under L2 until visualization. Imaging of cryoTEM samples was made on a JEM-2200FS/CR
transmission electron microscope operated at 200 kV. An in-column omega energy filter
helped to record images with improved signal to noise ratio by zero-loss filtering. The energy
selecting slit width was set at 9 eV. Digital images were recorded on UltraScan4000 CCD cam-
era (Gatan Inc.) under low-dose conditions at a nominal magnification of 50,000x obtaining a
final pixel size of 2.7 Å/pixel. Cross-sectional membrane intensity profiles were calculated with
the image processing software ImageJ [71].
Surface plasmon resonance (SPR)
SPR data were collected using a BIAcore 3000 system (GE Healthcare) and a L1 sensor chip
(GE Healthcare), which contains alkyl chains for capturing liposomes. All SPR experiments
were performed in running buffer (10 mMHEPES pH 7.5, 150 mMNaCl, 1 mMDTT) at
25˚C. The L1 chip surface was conditioned with two injections of a mixture of isopropanol
and 50 mMNaOH at a ratio 2:3 (5 "l at 10 "l/min). After overnight dialysis at 4˚C against the
running buffer, a 2-fold serial dilution of SidD37-507 and SidDïloop was prepared (32 to
0.125 "M) in running buffer. For each concentration, 20 "M liposomes were immobilized over
the chip (10 "l at 5 "l/min) and any excess unbound liposomes were removed by injecting 5 "l
of 50 mMNaOH (10 "l/min flow rate). Uncovered sensor chip surface was blocked with a 0.2
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mg/ml BSA (10 "l at 5 "l/min) to avoid non-specific binding. Binding experiments were car-
ried out by injecting SidD37-507 or SidDïloop (40 "l at 20 "l/min) over the liposome-coated
chip. The L1 chip was regenerated and stripped of liposomes after each run by injecting a mix-
ture of isopropanol and 50 mMNaOH at a ratio 2:3 (5 "l at 10 "l/min) and 20 mM CHAPS
(5 "l at 10 "l/min). No loss of sensor chip binding capacity due to regeneration occurred, and
the capture of liposomes was similar in each run. The sensograms were processed using the
BIAcore 3000 BiaEvaluation software (GE Healthcare). Equilibrium dissociation constants
were obtained by fitting the maximum RUs reached at each SidD concentration to the steady-
state affinity model, assuming a 1:1 binding stoichiometry. Each experiment was done in
triplicate.
Ethics statement
All experiments were carried out in accordance with the recommendations in the Guide for
the Care and Use of Laboratory Animals of the National Institutes of Health. The animal use
protocol was reviewed and approved by the Institutional Animal Care and Use Committee
(IACUC) of NIH (protocol number ASP#18–084).
Supporting information
S1 Fig. Zn2+ identification.
(TIF)
S2 Fig. Lipid-protein overlay assay with SidD37-507.
(TIF)
S3 Fig. SPR sensograms of SidD37-507 and SidDïloop.
(TIF)
S4 Fig. Deletion of the hydrophobic loop does not significantly alter the structure of SidD
or interdomain flexibility.
(TIF)
S5 Fig. Two charged patches near the loop region do not affect the CTD selectivity for
membranes.
(TIF)
S6 Fig. Subcellular localization of CTDmutants.
(TIF)
S7 Fig. Mutational analysis of the C-terminal ċ-helix bundle.
(TIF)
S8 Fig. Study of Legionella with a sidDïloop allele.
(TIF)
S9 Fig. The catalytic triad within CTD does not affect Rab1 dynamics on LCVs.
(TIF)
S10 Fig. Cysteine analog and synthetic peptide binding to SidD.
(TIF)
S11 Fig. SidD or CTD does not affect the lipidation state of Rab1.
(TIF)
PLOS PATHOGENS Membrane targeting of SidD
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008734 August 27, 2020 21 / 26
S12 Fig. SidD or CTD does not display lipid phosphatase activity.
(TIF)
S13 Fig. SidD or SidD CTD does not display phospholipase activity.
(TIF)
S1 Table. Data collection and refinement statistics.
(DOCX)
S2 Table. Plasmids used in this study.
(DOCX)
S3 Table. Oligonucleotides used in this study.
(DOCX)




We thank members of the Machner lab (Yi-han Lin, Pei-Chung Lee, Nicole Ellis, Katherine
Bonnington, and Stephanie Lehman) and the Hierro lab for technical support and critical
reading of the manuscript.
Author Contributions
Conceptualization: Igor Tascón, Xiao Li.
Formal analysis: Igor Tascón, Xiao Li.
Funding acquisition: Aitor Hierro, Matthias P. Machner.
Investigation: Igor Tascón, Xiao Li, Marı́a Lucas, D’anna Nelson, Ander Vidaurrazaga, Yi-
Han Lin, Adriana L. Rojas.
Methodology: Igor Tascón, Xiao Li.
Supervision: Aitor Hierro, Matthias P. Machner.
Writing – original draft: Xiao Li.
Writing – review & editing: Xiao Li, Aitor Hierro, Matthias P. Machner.
References
1. Salomon D, Orth K. What pathogens have taught us about posttranslational modifications. Cell host &
microbe. 2013; 14(3):269–79.
2. Shapiro BM, Kingdon HS, Stadtman ER. Regulation of glutamine synthetase. VII. Adenylyl glutamine
synthetase: a new form of the enzyme with altered regulatory and kinetic properties. Proc Natl Acad Sci
U S A. 1967; 58(2):642–9. https://doi.org/10.1073/pnas.58.2.642 PMID: 4860756
3. Wulff K, Mecke D, Holzer H. Mechanism of the enzymatic inactivation of glutamine synthetase from E.
coli. Biochemical and biophysical research communications. 1967; 28(5):740–5. https://doi.org/10.
1016/0006-291x(67)90378-6 PMID: 4861255
4. Yarbrough ML, Li Y, Kinch LN, Grishin NV, Ball HL, Orth K. AMPylation of Rho GTPases by Vibrio
VopS disrupts effector binding and downstream signaling. Science. 2009; 323(5911):269–72. https://
doi.org/10.1126/science.1166382 PMID: 19039103
PLOS PATHOGENS Membrane targeting of SidD
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008734 August 27, 2020 22 / 26
5. Worby CA, Mattoo S, Kruger RP, Corbeil LB, Koller A, Mendez JC, et al. The Fic domain: A new para-
digm for adenylylation. Molecular cell. 2009; 34(1):93. https://doi.org/10.1016/j.molcel.2009.03.008
PMID: 19362538
6. Muller MP, Peters H, Blumer J, Blankenfeldt W, Goody RS, Itzen A. The Legionella effector protein
DrrA AMPylates the membrane traffic regulator Rab1b. Science. 2010; 329(5994):946–9. https://doi.
org/10.1126/science.1192276 PMID: 20651120
7. Colicelli J. Human RAS superfamily proteins and related GTPases. Science’s STKE: signal transduc-
tion knowledge environment. 2004; 2004(250):Re13. https://doi.org/10.1126/stke.2502004re13 PMID:
15367757
8. Mishra AK, Lambright DG. Invited review: Small GTPases and their GAPs. Biopolymers. 2016; 105
(8):431–48. https://doi.org/10.1002/bip.22833 PMID: 26972107
9. Isberg RR, O’Connor TJ, HeidtmanM. The Legionella pneumophila replication vacuole: making a cosy
niche inside host cells. Nature reviews Microbiology. 2009; 7(1):13–24. https://doi.org/10.1038/
nrmicro1967 PMID: 19011659
10. Ensminger AW, Isberg RR. Legionella pneumophila Dot/Icm translocated substrates: a sum of parts.
Curr Opin Microbiol. 2009; 12(1):67–73. https://doi.org/10.1016/j.mib.2008.12.004 PMID: 19157961
11. Ninio S, Roy CR. Effector proteins translocated by Legionella pneumophila: strength in numbers.
Trends in microbiology. 2007; 15(8):372–80. https://doi.org/10.1016/j.tim.2007.06.006 PMID:
17632005
12. Segal G, Purcell M, Shuman HA. Host cell killing and bacterial conjugation require overlapping sets of
genes within a 22-kb region of the Legionella pneumophila genome. Proc Natl Acad Sci U S A. 1998; 95
(4):1669–74. https://doi.org/10.1073/pnas.95.4.1669 PMID: 9465074
13. Vogel JP, Andrews HL,Wong SK, Isberg RR. Conjugative transfer by the virulence system of Legionella
pneumophila. Science. 1998; 279(5352):873–6. https://doi.org/10.1126/science.279.5352.873 PMID:
9452389
14. Horwitz MA. Formation of a novel phagosome by the Legionnaires’ disease bacterium (Legionella pneu-
mophila) in humanmonocytes. The Journal of experimental medicine. 1983; 158(4):1319–31. https://
doi.org/10.1084/jem.158.4.1319 PMID: 6619736
15. Sherwood RK, Roy CR. A Rab-centric perspective of bacterial pathogen-occupied vacuoles. Cell host
& microbe. 2013; 14(3):256–68.
16. Spano S, Galan JE. Taking control: Hijacking of Rab GTPases by intracellular bacterial pathogens.
Small GTPases. 2018; 9(1–2):182–91. https://doi.org/10.1080/21541248.2017.1336192 PMID:
28632996
17. Plutner H, Cox AD, Pind S, Khosravi-Far R, Bourne JR, Schwaninger R, et al. Rab1b regulates vesicu-
lar transport between the endoplasmic reticulum and successive Golgi compartments. J Cell Biol. 1991;
115(1):31–43. https://doi.org/10.1083/jcb.115.1.31 PMID: 1918138
18. Kagan JC, Stein MP, Pypaert M, Roy CR. Legionella subvert the functions of Rab1 and Sec22b to cre-
ate a replicative organelle. The Journal of experimental medicine. 2004; 199(9):1201–11. https://doi.
org/10.1084/jem.20031706 PMID: 15117975
19. Derre I, Isberg RR. Legionella pneumophila replication vacuole formation involves rapid recruitment of
proteins of the early secretory system. Infect Immun. 2004; 72(5):3048–53. https://doi.org/10.1128/iai.
72.5.3048-3053.2004 PMID: 15102819
20. Murata T, Delprato A, Ingmundson A, Toomre DK, Lambright DG, Roy CR. The Legionella pneumophila
effector protein DrrA is a Rab1 guanine nucleotide-exchange factor. Nature cell biology. 2006; 8
(9):971–7. https://doi.org/10.1038/ncb1463 PMID: 16906144
21. Machner MP, Isberg RR. Targeting of host Rab GTPase function by the intravacuolar pathogen Legio-
nella pneumophila. Developmental cell. 2006; 11(1):47–56. https://doi.org/10.1016/j.devcel.2006.05.
013 PMID: 16824952
22. Machner MP, Isberg RR. A bifunctional bacterial protein links GDI displacement to Rab1 activation. Sci-
ence. 2007; 318(5852):974–7. https://doi.org/10.1126/science.1149121 PMID: 17947549
23. Tan Y, Luo ZQ. Legionella pneumophila SidD is a deAMPylase that modifies Rab1. Nature. 2011; 475
(7357):506–9. https://doi.org/10.1038/nature10307 PMID: 21734656
24. Neunuebel MR, Chen Y, Gaspar AH, Backlund PS Jr., Yergey A, Machner MP. De-AMPylation of the
small GTPase Rab1 by the pathogen Legionella pneumophila. Science. 2011; 333(6041):453–6.
https://doi.org/10.1126/science.1207193 PMID: 21680813
25. Chen Y, Tascon I, Neunuebel MR, Pallara C, Brady J, Kinch LN, et al. Structural basis for Rab1 de-
AMPylation by the Legionella pneumophila effector SidD. PLoS Pathog. 2013; 9(5):e1003382. https://
doi.org/10.1371/journal.ppat.1003382 PMID: 23696742
PLOS PATHOGENS Membrane targeting of SidD
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008734 August 27, 2020 23 / 26
26. Schneidman-Duhovny D, Hammel M, Tainer JA, Sali A. FoXS, FoXSDock and MultiFoXS: Single-state
and multi-state structural modeling of proteins and their complexes based on SAXS profiles. Nucleic
acids research. 2016; 44(W1):W424–9. https://doi.org/10.1093/nar/gkw389 PMID: 27151198
27. Killian JA, von Heijne G. How proteins adapt to a membrane–water interface. Trends in Biochemical
Sciences. 2000; 25(9):429–34. https://doi.org/10.1016/s0968-0004(00)01626-1 PMID: 10973056
28. Cowan SW, Schirmer T, Rummel G, Steiert M, Ghosh R, Pauptit RA, et al. Crystal structures explain
functional properties of two E. coli porins. Nature. 1992; 358(6389):727–33. https://doi.org/10.1038/
358727a0 PMID: 1380671
29. Hartmann E, Rapoport TA, Lodish HF. Predicting the orientation of eukaryotic membrane-spanning pro-
teins. Proceedings of the National Academy of Sciences of the United States of America. 1989; 86
(15):5786–90. https://doi.org/10.1073/pnas.86.15.5786 PMID: 2762295
30. Sato M, Hresko R, Mueckler M. Testing the Charge Difference Hypothesis for the Assembly of a Eucar-
yotic Multispanning Membrane Protein. Journal of Biological Chemistry. 1998; 273(39):25203–8.
https://doi.org/10.1074/jbc.273.39.25203 PMID: 9737982
31. Thomas LL, van der Vegt SA, Fromme JC. A Steric Gating MechanismDictates the Substrate Specific-
ity of a Rab-GEF. Developmental cell. 2019; 48(1):100–14.e9. https://doi.org/10.1016/j.devcel.2018.11.
013 PMID: 30528786
32. Li F, Yi L, Zhao L, Itzen A, Goody RS, Wu Y-W. The role of the hypervariable C-terminal domain in Rab
GTPasesmembrane targeting. Proceedings of the National Academy of Sciences. 2014; 111(7):2572.
33. Hicks SW, Galán JE. Exploitation of Eukaryotic Subcellular Targeting Mechanisms by Bacterial Effec-
tors. Nature reviews Microbiology. 2013; 11(5):https://doi.org/10.1038/nrmicro3009 PMID: 23588250
34. Campodonico EM, Roy CR, Ninio S. Legionella pneumophila Type IV Effectors YlfA and YlfB Are
SNARE-Like Proteins that Form Homo- and Heteromeric Complexes and Enhance the Efficiency of
Vacuole Remodeling. PLoS ONE. 2016; 11(7):e0159698. https://doi.org/10.1371/journal.pone.
0159698 PMID: 27459495
35. Horenkamp FA, Kauffman KJ, Kohler LJ, Sherwood RK, Krueger KP, Shteyn V, et al. The Legionella
Anti-autophagy Effector RavZ Targets the Autophagosome via PI3P- and Curvature-Sensing Motifs.
Developmental cell. 2015; 34(5):569–76. https://doi.org/10.1016/j.devcel.2015.08.010 PMID:
26343456
36. Neunuebel MR, Mohammadi S, Jarnik M, Machner MP. Legionella pneumophila LidA affects nucleotide
binding and activity of the host GTPase Rab1. Journal of bacteriology. 2012; 194(6):1389–400. https://
doi.org/10.1128/JB.06306-11 PMID: 22228731
37. Brombacher E, Urwyler S, Ragaz C, Weber SS, Kami K, Overduin M, et al. Rab1 guanine nucleotide
exchange factor SidM is a major phosphatidylinositol 4-phosphate-binding effector protein of Legionella
pneumophila. The Journal of biological chemistry. 2009; 284(8):4846–56. https://doi.org/10.1074/jbc.
M807505200 PMID: 19095644
38. Luo X, Wasilko DJ, Liu Y, Sun J, Wu X, Luo Z-Q, et al. Structure of the Legionella Virulence Factor,
SidC Reveals a Unique PI(4)P-Specific Binding Domain Essential for Its Targeting to the Bacterial Pha-
gosome. PLoS Pathogens. 2015; 11(6):e1004965. https://doi.org/10.1371/journal.ppat.1004965 PMID:
26067986
39. Pike CM, Boyer-Andersen R, Kinch LN, Caplan JL, Neunuebel MR. The Legionella effector RavD binds
phosphatidylinositol-3-phosphate and helps suppress endolysosomal maturation of the Legionella-con-
taining vacuole. The Journal of biological chemistry. 2019; 294(16):6405–15. https://doi.org/10.1074/
jbc.RA118.007086 PMID: 30733336
40. Nachmias N, Zusman T, Segal G. Study of Legionella Effector Domains Revealed Novel and Prevalent
Phosphatidylinositol 3-Phosphate Binding Domains. Infect Immun. 2019; 87(6). https://doi.org/10.1128/
IAI.00153-19 PMID: 30962397
41. Patel JC, Hueffer K, Lam TT, Galán JE. Diversification of a Salmonella virulence effector protein func-
tion by ubiquitin-dependent differential localization. Cell. 2009; 137(2):283–94. https://doi.org/10.1016/j.
cell.2009.01.056 PMID: 19379694
42. Price CT, Al-Quadan T, Santic M, Jones SC, Abu Kwaik Y. Exploitation of conserved eukaryotic host
cell farnesylation machinery by an F-box effector of Legionella pneumophila. The Journal of experimen-
tal medicine. 2010; 207(8):1713–26. https://doi.org/10.1084/jem.20100771 PMID: 20660614
43. Ivanov SS, Charron G, Hang HC, Roy CR. Lipidation by the host prenyltransferase machinery facilitates
membrane localization of Legionella pneumophila effector proteins. The Journal of biological chemistry.
2010; 285(45):34686–98. https://doi.org/10.1074/jbc.M110.170746 PMID: 20813839
44. Lin YH, Doms AG, Cheng E, Kim B, Evans TR, Machner MP. Host Cell-catalyzed S-Palmitoylation
Mediates Golgi Targeting of the Legionella Ubiquitin Ligase GobX. The Journal of biological chemistry.
2015; 290(42):25766–81. https://doi.org/10.1074/jbc.M115.637397 PMID: 26316537
PLOS PATHOGENS Membrane targeting of SidD
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008734 August 27, 2020 24 / 26
45. King NP, Newton P, Schuelein R, Brown DL, Petru M, Zarsky V, et al. Soluble NSF attachment protein
receptor molecular mimicry by a Legionella pneumophila Dot/Icm effector. Cell Microbiol. 2015; 17
(6):767–84. https://doi.org/10.1111/cmi.12405 PMID: 25488819
46. Geissler B. Bacterial Toxin Effector-Membrane Targeting: Outside in, then Back Again. Frontiers in Cel-
lular and Infection Microbiology. 2012; 2:75. https://doi.org/10.3389/fcimb.2012.00075 PMID:
22919666
47. Zhang Y, Barbieri JT. A Leucine-Rich Motif Targets Pseudomonas aeruginosa ExoS within Mammalian
Cells. Infection and Immunity. 2005; 73(12):7938–45. https://doi.org/10.1128/IAI.73.12.7938-7945.
2005 PMID: 16299285
48. Zhang Y, Deng Q, Porath JA, Williams CL, Pederson-Gulrud KJ, Barbieri JT. Plasmamembrane locali-
zation affects the RhoGAP specificity of Pseudomonas ExoS. Cell Microbiol. 2007; 9(9):2192–201.
https://doi.org/10.1111/j.1462-5822.2007.00949.x PMID: 17490406
49. Isaksson EL, Aili M, Fahlgren A, Carlsson SE, Rosqvist R, Wolf-Watz H. The membrane localization
domain is required for intracellular localization and autoregulation of YopE in Yersinia pseudotuberculo-
sis. Infect Immun. 2009; 77(11):4740–9. https://doi.org/10.1128/IAI.00333-09 PMID: 19687205
50. Horwitz MA. The Legionnaires’ disease bacterium (Legionella pneumophila) inhibits phagosome-lyso-
some fusion in humanmonocytes. The Journal of experimental medicine. 1983; 158(6):2108–26.
https://doi.org/10.1084/jem.158.6.2108 PMID: 6644240
51. Weber SS, Ragaz C, Reus K, Nyfeler Y, Hilbi H. Legionella pneumophila exploits PI(4)P to anchor
secreted effector proteins to the replicative vacuole. PLoS Pathog. 2006; 2(5):e46. https://doi.org/10.
1371/journal.ppat.0020046 PMID: 16710455
52. Dong N, Niu M, Hu L, Yao Q, Zhou R, Shao F. Modulation of membrane phosphoinositide dynamics by
the phosphatidylinositide 4-kinase activity of the Legionella LepB effector. Nature microbiology. 2016;
2:16236. https://doi.org/10.1038/nmicrobiol.2016.236 PMID: 27941800
53. Hsu F, ZhuW, Brennan L, Tao L, Luo ZQ, Mao Y. Structural basis for substrate recognition by a unique
Legionella phosphoinositide phosphatase. Proc Natl Acad Sci U S A. 2012; 109(34):13567–72. https://
doi.org/10.1073/pnas.1207903109 PMID: 22872863
54. Toulabi L, Wu X, Cheng Y, Mao Y. Identification and structural characterization of a Legionella phos-
phoinositide phosphatase. The Journal of biological chemistry. 2013; 288(34):24518–27. https://doi.
org/10.1074/jbc.M113.474239 PMID: 23843460
55. Schoebel S, Blankenfeldt W, Goody RS, Itzen A. High-affinity binding of phosphatidylinositol 4-phos-
phate by Legionella pneumophila DrrA. EMBO reports. 2010; 11(8):598–604. https://doi.org/10.1038/
embor.2010.97 PMID: 20616805
56. Del Campo CM, Mishra AK, Wang Y-H, Roy CR, Janmey PA, Lambright DG. Structural Basis for PI(4)
P-Specific Membrane Recruitment of the Legionella pneumophila Effector DrrA/SidM. Structure (Lon-
don, England: 1993). 2014; 22(3):397–408.
57. Berger KH, Isberg RR. Two distinct defects in intracellular growth complemented by a single genetic
locus in Legionella pneumophila. Mol Microbiol. 1993; 7(1):7–19. https://doi.org/10.1111/j.1365-2958.
1993.tb01092.x PMID: 8382332
58. Feeley JC, Gibson RJ, Gorman GW, Langford NC, Rasheed JK, Mackel DC, et al. Charcoal-yeast
extract agar: primary isolation medium for Legionella pneumophila. Journal of Clinical Microbiology.
1979; 10(4):437–41. https://doi.org/10.1128/JCM.10.4.437-441.1979 PMID: 393713
59. Sexton JA, Vogel JP. Regulation of hypercompetence in Legionella pneumophila. Journal of bacteriol-
ogy. 2004; 186(12):3814–25. https://doi.org/10.1128/JB.186.12.3814-3825.2004 PMID: 15175295
60. SwansonMS, Isberg RR. Association of Legionella pneumophila with the macrophage endoplasmic
reticulum. Infection and Immunity. 1995; 63(9):3609–20. https://doi.org/10.1128/IAI.63.9.3609-3620.
1995 PMID: 7642298
61. KabschW. XDS. Acta crystallographica Section D, Biological crystallography. 2010; 66(Pt 2):125–32.
https://doi.org/10.1107/S0907444909047337 PMID: 20124692
62. Vonrhein C, Blanc E, Roversi P, Bricogne G. Automated structure solution with autoSHARP. Methods
in molecular biology (Clifton, NJ). 2007; 364:215–30.
63. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, et al. PHENIX: a comprehensive
Python-based system for macromolecular structure solution. Acta crystallographica Section D, Biologi-
cal crystallography. 2010; 66(Pt 2):213–21. https://doi.org/10.1107/S0907444909052925 PMID:
20124702
64. Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta crystallographica
Section D, Biological crystallography. 2010; 66(Pt 4):486–501. https://doi.org/10.1107/
S0907444910007493 PMID: 20383002
PLOS PATHOGENS Membrane targeting of SidD
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008734 August 27, 2020 25 / 26
65. Franke D, Petoukhov MV, Konarev PV, Panjkovich A, Tuukkanen A, Mertens HDT, et al. ATSAS 2.8: a
comprehensive data analysis suite for small-angle scattering frommacromolecular solutions. Journal of
applied crystallography. 2017; 50(Pt 4):1212–25. https://doi.org/10.1107/S1600576717007786 PMID:
28808438
66. Franke D, Svergun DI. DAMMIF, a program for rapid ab-initio shape determination in small-angle scat-
tering. Journal of applied crystallography. 2009; 42(Pt 2):342–6. https://doi.org/10.1107/
S0021889809000338 PMID: 27630371
67. Volkov VV, Svergun DI. Uniqueness of ab initio shape determination in small-angle scattering. 2003; 36
(3-1):860–4.
68. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera—a
visualization system for exploratory research and analysis. Journal of computational chemistry. 2004;
25(13):1605–12. https://doi.org/10.1002/jcc.20084 PMID: 15264254
69. Kozin MB, Svergun DI. Automated matching of high- and low-resolution structural models. Journal of
applied crystallography. 2001; 34(1):33–41.
70. Svergun D, Barberato C, Koch MHJ. CRYSOL–a Program to Evaluate X-ray Solution Scattering of Bio-
logical Macromolecules from Atomic Coordinates. Journal of applied crystallography. 1995; 28(6):768–
73.
71. Schneider CA, RasbandWS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Meth-
ods. 2012; 9(7):671–5. https://doi.org/10.1038/nmeth.2089 PMID: 22930834
PLOS PATHOGENS Membrane targeting of SidD
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008734 August 27, 2020 26 / 26
